Subcutaneous (SC) Injections Subcutaneous injections involve injecting B12 into the fatty tissue just beneath the skin
These include: Nausea, vomiting, and diarrhoea (very common, especially during dose escalation) Reduced appetite and abdominal discomfort Constipation Risk of hypoglycaemia when used with insulin or sulphonylureas Pancreatitis and gallbladder disease have been reported Thyroid C-cell tumours have been observed in animal studies, though the relevance to humans is unknown Important safety considerations when using both treatments include: Mounjaro can reduce the effectiveness of oral contraceptives due to delayed gastric emptying
[5] Increased levels of TB-500 have been associated with reduced inflammation at the injury site, which may promote skeletal muscle regeneration after an injury
The 30mg format supports extended studies, multiple experimental replicates, and reduced batch variability in advanced research projects
When to Contact Your GP About B12 Treatment Whilst B12 injections are generally safe and well-tolerated, certain situations warrant prompt medical review
